Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-140-5 | CAS number: 7789-00-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 17/1/1983-23/2/1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline-comparable proprietary study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- Pre-dates GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Sodium chromate
- EC Number:
- 231-889-5
- EC Name:
- Sodium chromate
- Cas Number:
- 7775-11-3
- Molecular formula:
- CrH2O4.2Na
- IUPAC Name:
- disodium dioxido(dioxo)chromium
- Reference substance name:
- Sodium dichromate
- EC Number:
- 234-190-3
- EC Name:
- Sodium dichromate
- Cas Number:
- 10588-01-9
- Molecular formula:
- Cr2Na2O7
- IUPAC Name:
- sodium dichromate
- Reference substance name:
- Potassium dichromate
- EC Number:
- 231-906-6
- EC Name:
- Potassium dichromate
- Cas Number:
- 7778-50-9
- Molecular formula:
- Cr2H2O7.2K
- IUPAC Name:
- sodium dichromate
- Details on test material:
- Sodium chromate: yellow powder
Sodium dichromae: orange/red powder
Potassium dichromate: orange/red powder
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, UK
- Age at study initiation: 7-9 weeks
- Weight at study initiation: Not detailed
- Fasting period before study: 18h
- Housing: Individual
- Diet: ad libitum except pre-dosing period
- Water: ad libitum
- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17-21
- Humidity (%): 24*-74
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 5% w/v
- Amount of vehicle (if gavage): variable
- Justification for choice of vehicle: solubility of test material
- Lot/batch no. (if required): -
- Purity: : - Doses:
- Sodium chromate: 0.2, 0.5, 1.5, 3.0, 5.0 ml/kg; equivalent to 10, 25, 75, 150 and 250 mg/kg bw
Sodium dichromate: 0.2, 0.5, 1.5, 3.0 and 5.0 ml/kg; equivalent to 10, 25, 75, 150 and 250 mg/kg bw
Potassium dichromate: 0.5, 1.0, 2.0, 4.0 and 6.0 ml/kg; equivalent to 25, 50, 100, 200 and 300 mg/kg bw - No. of animals per sex per dose:
- Five/sex
- Control animals:
- yes
- Details on study design:
- Animals were administered a single gavage dose and observed for 14 days. Rats were weighed on Days 1, 4, 7, 11 and 14. Gross necropsy was performed on all animals, weights of the brain, lungs, liver, spleen, kidneys and gonads were recorded.
- Statistics:
- Homogeneity of variance was establised using the F-max test, follwoed by Student;s t-test or Wilcoxon Rank Sum test.
Results and discussion
- Preliminary study:
- Dose levels of 0.2, 1.0, 2.0, 4.0 and 6.0 ml/kg bw were used for each compound; equivalent to 10, 50, 100, 200 and 300 mg/kg bw. Deaths occurred at >=100 mg/kg bw (sodium chromate), at >=200 mg/kg bw (sodium dichromate) and at >= 200 mg/kg bw (potassium dichromate).
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 129.5 mg/kg bw
- 95% CL:
- 118.5 - 142
- Remarks on result:
- other: Sodium chromate
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 67 mg/kg bw
- 95% CL:
- 58.5 - 77
- Remarks on result:
- other: Sodium chromate
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 123.5 mg/kg bw
- 95% CL:
- 107 - 142.5
- Remarks on result:
- other: Sodium dichromate
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 86.5 mg/kg bw
- 95% CL:
- 74 - 101
- Remarks on result:
- other: Sodium dichromate
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 168 mg/kg bw
- 95% CL:
- 154.5 - 182.5
- Remarks on result:
- other: Potassium dichromate
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 90.5 mg/kg bw
- 95% CL:
- 81.5 - 100.5
- Remarks on result:
- other: Potassium dichromate
- Mortality:
- Sodium chromate:
In the main study, mortality occurred at dose levels of >=75 mg/kg bw (females) and >=150 mg/kg bw (males) within one day of dosing.
Sodium dichromate:
In the main study, mortality occurred at dose levels of >=75 mg/kg bw (females) and >=150 mg/kg bw (males) within two days of dosing
Potassium dichromate:
In the main study, mortality occurred at dose levels of >=100 mg/kg bw (females) and >=200 mg/kg bw (males) within one day of dosing - Clinical signs:
- other: Sodium chromate: piloerection, tremors, hyperkinesia, sedation, hunched posture, ataxia, diarrhoea, coma (30 minutes - 6 days) Sodium dichromate: piloerection, hypothermia, hunched posture, hyperkinesia, hypokinesia, prostration, ataxia, diarrhoea, sedati
- Gross pathology:
- Sodium chromate: reddened gastric mucosa with abnormal (green) coloring and contents; green areas on lungs
Sodium dichromate: reddened gastric mucosa with abnormal (green) coloring and contents; green areas on lungs
Potassium dichromate: distended and reddened gastric mucosa with abnormal (green) coloring; green areas on lungs - Other findings:
- Organ weights were unaffected by treatment with any compound
Any other information on results incl. tables
Dose level |
Mortality |
||||||
Sodium chromate |
Sodium dichromate |
Potassium dichromate |
|||||
ml/kg bw |
mg/kg bw |
M |
F |
M |
F |
M |
F |
6.0 |
0 (controls) |
0 |
0 |
0 |
0 |
0 |
0 |
0.2 |
10 |
0 |
0 |
0 |
0 |
- |
- |
0.5 |
25 |
0 |
0 |
0 |
0 |
0 |
0 |
1.0 |
50 |
- |
- |
- |
- |
0 |
0 |
1.5 |
75 |
0 |
1 |
0 |
1 |
- |
- |
2.0 |
100 |
- |
- |
- |
- |
0 |
4 |
3.0 |
150 |
4 |
5 |
5 |
4 |
- |
- |
4.0 |
200 |
- |
- |
- |
- |
4 |
5 |
5.0 |
250 |
5 |
5 |
4 |
5 |
- |
- |
6.0 |
300 |
- |
- |
- |
- |
5 |
5 |
Applicant's summary and conclusion
- Interpretation of results:
- toxic
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The results of this study indicate that sodium chromate, sodium dichromate and potassium dichromate are classified as (R25) 'Toxic if swallowed' according to EU criteria.
- Executive summary:
Groups of rats (5/sex) were gavaged with single doses of sodium chromate, sodium dichromate or potassium dichromate (in water) at dose levels of between 10 and 300 mg/kg bw. Animals were observed for 14 days. Bodyweights were recorded on Days 1, 4, 7, 11 and 14. Gross necropsy was performed on all animals and organ weights recorded.
Deaths occurred at dose levels of >=75 mg/kg bw (sodium chromate, sodium, dichromate) and at >=100 mg/kg bw (potassium dichromate): females were slightly more sensitive than males for all compounds. Signs of toxicity were observed in all groups and included hunched posture, tremors, hypokinesia, sedation, prostration, coma, piloerection, ataxia, diarrhoea, dacryorrhoea and hyperkinesia. Slightly reduced weight gain was seen in some surviving animals. Findings at necropsy were limited to reddening and staining of the stomach, abnormal gastric contents and green staining of the lungs. Organ weights were unaffected by treatment.
LD 50 values were calculated to be:
Sodium chromate: 129.5 (118.5 -142.0) mg/kg bw in males; 67.0 (58.5 -77.0) mg/kg bw in females
Sodium dichromate: 123.5 (107.0 -142.5) mg/kg bw in males; 86.5 (74.0 -101.0) mg/kg bw in females
Potassium dichromate: 168.0 (154.5 -182.5) mg/kg bw in males; 90.5 (81.5 -100.5) mg/kg bw in females
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
